Scholars Central

Conference abstractPublished 6 Oct 2015

Novel biodegradable polymeric nanoparticle development using quality by design

Authors: Emmanuel O Akala

Howard University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The relatively new concept of quality by design (QbD) in pharmaceutical dosage form design and development, already incorporated into automakersâÂ?Â? production principles, involves designing and developing drug formulations and manufacturing processes which ensure predefined drug product specifications. An important part of QbD is to understand how process and formulation variables affect product characteristics and subsequent optimization of these variables vis-Ã? -vis the final specifications. Statistical design of experiments (DoE) is a well-established method for identifying important parameters in a pharmaceutical dosage form design and optimizing the parameters with respect to certain specifications; DoE is a valuable tool to establish in mathematical form the relationships between critical process parameters (CPPs) together with the critical material attributes (CMAs) and critical quality attributes (CQAs). Further, DoE can help identify optimal conditionsquickly as well as facilitate robustness testing. Approaches to DoE (to examine all the variables simultaneously) are factorial and mixture experimental designs. When the responses or nanoparticle properties are known to depend on the proportions of the ingredients, DoE involving mixture methodologyis preferred. When a formulation is a mixture of various components (proportion of the constituents: macomonomer, crosslinker, stabilizer and initiator system) as studied in this work and the levels of the components are constrained, D-optimal mixture design is more useful than a factorial design because it accounts for the dependence of response on proportionality of constituents. Our data on two nanoparticle systems (fabricated by surfactant-free dispersion polymerization) will be presented: stealth biodegradable palctaxelloaded polylactide nanoparticles and stealth biodegradable docetaxel-loaded poly-Ã?µ-caprolactone nanoparticles.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Emmanuel O Akala”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels